CEO
Profile summary: ArcherDX CEO
Genapsys
Genapsys provides an integrated platform for genomic sequencing and analysis, designed to streamline complex workflows for researchers and clinicians. The system combines high-throughput sequencing technology with automated bioinformatics pipelines to accelerate data interpretation and improve accuracy in genomic studies. It targets academic, pharmaceutical, and clinical diagnostic laboratories focused on precision medicine.
- Biotechnology
- Healthcare Technology
- Hardware
Updated 1 month ago
Funding
Raised to date
$250MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
$206M across 4 disclosed rounds
FC+4$70M · Series D
Announced May 2021 · from article date
Disclosed cumulative: $206M
4/4
Reported total $250M
Incomplete round history. $44M of the $250M reported total isn’t matched to a known round.
RoundDateAmountValuationInvestors
Founders
Product
Problem
Traditional genomic sequencing workflows are time-consuming and complex, hindering rapid data analysis for researchers and clinicians. This complexity delays critical discoveries in personalized medicine and disease research, impacting the pace of scientific advancement.
Solution
Genapsys offers an integrated platform designed to streamline genomic sequencing and analysis. The system provides rapid and accurate DNA sequencing capabilities, enabling faster turnaround times for biological data interpretation. By simplifying complex bioinformatics pipelines, Genapsys empowers users to accelerate their research and clinical applications. The platform's architecture is built to enhance throughput and data quality, facilitating deeper insights from genomic studies.
Target Audience
The primary customers are academic research institutions, pharmaceutical companies, and clinical diagnostic laboratories focused on genomics and precision medicine.
Features
- High-throughput sequencing technology for accelerated sample processing
- Integrated bioinformatics pipeline for automated data analysis and variant calling
- Proprietary algorithms for enhanced accuracy in genomic data interpretation
- Scalable architecture to accommodate varying research and clinical demands
- User-friendly interface for simplified workflow management